Inhibikase Therapeutics I... (IKT)
1.90
-0.08 (-4.04%)
At close: Apr 17, 2025, 3:59 PM
Inhibikase Therapeutics Revenue
Inhibikase Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Inhibikase Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
15
Market Cap
141.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 260.5K | +111.03% |
| Dec 31, 2022 | 123.44K | -96.02% |
| Dec 31, 2021 | 3.1M | +343.92% |
| Dec 31, 2020 | 698.47K | n/a |